methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride

methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride Struktur
1821717-21-8
CAS-Nr.
1821717-21-8
Englisch Name:
methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride
Synonyma:
Tofacitinib Impurity 201;Tofacitinib Impurity 12 HCl;Tofacitinib Impurity 10 HCl;Tofacitinib Impurity 108 HCL;methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride;Carbamic acid, N-[(3R,4R)-4-methyl-3-piperidinyl]-, methyl ester
CBNumber:
CB13355054
Summenformel:
C8H16N2O2
Molgewicht:
172.22
MOL-Datei:
1821717-21-8.mol

methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride Eigenschaften

Siedepunkt:
277.9±29.0 °C(Predicted)
Dichte
1.05±0.1 g/cm3(Predicted)
pka
12.13±0.40(Predicted)

Sicherheit

methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai zhigan biotechnology co., LTD
zhiqianbio@126.com China 19785 58
Jinan blalong chemical co. LTD 2710913286@.com
1513643261@qq.com China 14253 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341 13101896326
shiqingran@wzxchem.com China 1967 58
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212
2885426135@qq.com China 6427 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 18924305345
LK@zlstandards.com China 6348 58

1821717-21-8()Verwandte Suche:


  • methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride
  • Carbamic acid, N-[(3R,4R)-4-methyl-3-piperidinyl]-, methyl ester
  • Tofacitinib Impurity 201
  • Tofacitinib Impurity 108 HCL
  • Tofacitinib Impurity 10 HCl
  • Tofacitinib Impurity 12 HCl
  • 1821717-21-8
Copyright 2019 © ChemicalBook. All rights reserved